# OnCo record fulgent-genetics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/fulgent-genetics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "fulgent-genetics" ;
  schema:name "Fulgent Genetics"@en ;
  schema:alternateName "Fulgent Pharma"@en ;
  schema:description "Fulgent Genetics runs genetic tests, including tests for inherited cancer risk, and through its Fulgent Pharma business develops new forms of chemotherapy wrapped in nanoparticles. Its lead medicine, FID-007, is in a trial for advanced head and neck cancer."@en ;
  schema:url <https://onco.cc/companies/fulgent-genetics/>, <https://www.fulgentgenetics.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.fulgentgenetics.com/>, <https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/flgt-20251231.htm>, <https://clinicaltrials.gov/study/NCT06694480> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/recurrent-metastatic-hnscc/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/>, <https://onco.cc/fronts/chemotherapy/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/germline-testing/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:trials <https://onco.cc/trials/nct06332092/> .